nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2E1—Dacarbazine—muscle cancer	0.295	0.342	CbGbCtD
Tranylcypromine—CYP1A2—Dacarbazine—muscle cancer	0.17	0.198	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—muscle cancer	0.144	0.168	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—muscle cancer	0.0834	0.0969	CbGbCtD
Tranylcypromine—CYP3A4—Vincristine—muscle cancer	0.0477	0.0554	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—muscle cancer	0.0469	0.0544	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—muscle cancer	0.0437	0.0508	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—muscle cancer	0.0298	0.0346	CbGbCtD
Tranylcypromine—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.00447	0.0321	CcSEcCtD
Tranylcypromine—Myoclonus—Vincristine—muscle cancer	0.00431	0.031	CcSEcCtD
Tranylcypromine—Numbness—Vincristine—muscle cancer	0.00313	0.0225	CcSEcCtD
Tranylcypromine—Sensory loss—Vincristine—muscle cancer	0.003	0.0216	CcSEcCtD
Tranylcypromine—Neck stiffness—Methotrexate—muscle cancer	0.00264	0.019	CcSEcCtD
Tranylcypromine—Numbness—Etoposide—muscle cancer	0.00254	0.0182	CcSEcCtD
Tranylcypromine—Nuchal rigidity—Methotrexate—muscle cancer	0.00243	0.0175	CcSEcCtD
Tranylcypromine—Sensory loss—Etoposide—muscle cancer	0.00243	0.0175	CcSEcCtD
Tranylcypromine—Urinary retention—Vincristine—muscle cancer	0.00179	0.0129	CcSEcCtD
Tranylcypromine—Ataxia—Vincristine—muscle cancer	0.00177	0.0127	CcSEcCtD
Tranylcypromine—Agranulocytosis—Dactinomycin—muscle cancer	0.00152	0.0109	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Vincristine—muscle cancer	0.0015	0.0108	CcSEcCtD
Tranylcypromine—Hepatitis—Dactinomycin—muscle cancer	0.00146	0.0105	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Methotrexate—muscle cancer	0.0014	0.0101	CcSEcCtD
Tranylcypromine—Sweating—Vincristine—muscle cancer	0.00139	0.01	CcSEcCtD
Tranylcypromine—Flushing—Dactinomycin—muscle cancer	0.00135	0.00974	CcSEcCtD
Tranylcypromine—Chills—Dactinomycin—muscle cancer	0.00131	0.00942	CcSEcCtD
Tranylcypromine—Blood disorder—Doxorubicin—muscle cancer	0.00131	0.00939	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Vincristine—muscle cancer	0.0013	0.00933	CcSEcCtD
Tranylcypromine—Alopecia—Dactinomycin—muscle cancer	0.00129	0.00928	CcSEcCtD
Tranylcypromine—Anaemia—Dactinomycin—muscle cancer	0.00117	0.00845	CcSEcCtD
Tranylcypromine—Alopecia—Vincristine—muscle cancer	0.00115	0.00829	CcSEcCtD
Tranylcypromine—Leukopenia—Dactinomycin—muscle cancer	0.00114	0.00818	CcSEcCtD
Tranylcypromine—Agranulocytosis—Etoposide—muscle cancer	0.0011	0.0079	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Etoposide—muscle cancer	0.00105	0.00756	CcSEcCtD
Tranylcypromine—Anaemia—Vincristine—muscle cancer	0.00105	0.00755	CcSEcCtD
Tranylcypromine—Agitation—Vincristine—muscle cancer	0.00104	0.0075	CcSEcCtD
Tranylcypromine—Oedema—Dactinomycin—muscle cancer	0.00104	0.00746	CcSEcCtD
Tranylcypromine—Leukopenia—Vincristine—muscle cancer	0.00102	0.00731	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00101	0.0073	CcSEcCtD
Tranylcypromine—Anorexia—Dactinomycin—muscle cancer	0.000988	0.00711	CcSEcCtD
Tranylcypromine—Flushing—Etoposide—muscle cancer	0.00098	0.00705	CcSEcCtD
Tranylcypromine—Hypertension—Vincristine—muscle cancer	0.000979	0.00705	CcSEcCtD
Tranylcypromine—Chills—Etoposide—muscle cancer	0.000947	0.00682	CcSEcCtD
Tranylcypromine—Alopecia—Etoposide—muscle cancer	0.000933	0.00671	CcSEcCtD
Tranylcypromine—Oedema—Vincristine—muscle cancer	0.000926	0.00666	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vincristine—muscle cancer	0.000906	0.00652	CcSEcCtD
Tranylcypromine—Decreased appetite—Dactinomycin—muscle cancer	0.000901	0.00648	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Vincristine—muscle cancer	0.000895	0.00644	CcSEcCtD
Tranylcypromine—Pain—Dactinomycin—muscle cancer	0.000886	0.00638	CcSEcCtD
Tranylcypromine—Muscle spasms—Etoposide—muscle cancer	0.000883	0.00636	CcSEcCtD
Tranylcypromine—Anorexia—Vincristine—muscle cancer	0.000883	0.00635	CcSEcCtD
Tranylcypromine—Hypotension—Vincristine—muscle cancer	0.000865	0.00623	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—muscle cancer	0.000859	0.00619	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dactinomycin—muscle cancer	0.000854	0.00615	CcSEcCtD
Tranylcypromine—Anaemia—Etoposide—muscle cancer	0.000849	0.00611	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000847	0.0061	CcSEcCtD
Tranylcypromine—Insomnia—Vincristine—muscle cancer	0.000837	0.00603	CcSEcCtD
Tranylcypromine—Paraesthesia—Vincristine—muscle cancer	0.000831	0.00598	CcSEcCtD
Tranylcypromine—Leukopenia—Etoposide—muscle cancer	0.000823	0.00592	CcSEcCtD
Tranylcypromine—Abdominal pain—Dactinomycin—muscle cancer	0.000819	0.0059	CcSEcCtD
Tranylcypromine—Body temperature increased—Dactinomycin—muscle cancer	0.000819	0.0059	CcSEcCtD
Tranylcypromine—Loss of consciousness—Etoposide—muscle cancer	0.000808	0.00581	CcSEcCtD
Tranylcypromine—Decreased appetite—Vincristine—muscle cancer	0.000805	0.00579	CcSEcCtD
Tranylcypromine—Hypertension—Etoposide—muscle cancer	0.000793	0.00571	CcSEcCtD
Tranylcypromine—Pain—Vincristine—muscle cancer	0.000792	0.0057	CcSEcCtD
Tranylcypromine—Constipation—Vincristine—muscle cancer	0.000792	0.0057	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vincristine—muscle cancer	0.000757	0.00545	CcSEcCtD
Tranylcypromine—Confusional state—Etoposide—muscle cancer	0.000756	0.00544	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—muscle cancer	0.000744	0.00536	CcSEcCtD
Tranylcypromine—Asthenia—Dactinomycin—muscle cancer	0.000743	0.00535	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Etoposide—muscle cancer	0.000734	0.00528	CcSEcCtD
Tranylcypromine—Tachycardia—Etoposide—muscle cancer	0.000732	0.00527	CcSEcCtD
Tranylcypromine—Body temperature increased—Vincristine—muscle cancer	0.000732	0.00527	CcSEcCtD
Tranylcypromine—Abdominal pain—Vincristine—muscle cancer	0.000732	0.00527	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—muscle cancer	0.000728	0.00524	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Etoposide—muscle cancer	0.000725	0.00522	CcSEcCtD
Tranylcypromine—Anorexia—Etoposide—muscle cancer	0.000715	0.00514	CcSEcCtD
Tranylcypromine—Diarrhoea—Dactinomycin—muscle cancer	0.000709	0.0051	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—muscle cancer	0.000704	0.00507	CcSEcCtD
Tranylcypromine—Hypotension—Etoposide—muscle cancer	0.000701	0.00504	CcSEcCtD
Tranylcypromine—Sweating—Methotrexate—muscle cancer	0.000675	0.00486	CcSEcCtD
Tranylcypromine—Paraesthesia—Etoposide—muscle cancer	0.000673	0.00485	CcSEcCtD
Tranylcypromine—Somnolence—Etoposide—muscle cancer	0.000667	0.0048	CcSEcCtD
Tranylcypromine—Asthenia—Vincristine—muscle cancer	0.000664	0.00478	CcSEcCtD
Tranylcypromine—Vomiting—Dactinomycin—muscle cancer	0.000659	0.00474	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—muscle cancer	0.000657	0.00473	CcSEcCtD
Tranylcypromine—Rash—Dactinomycin—muscle cancer	0.000653	0.0047	CcSEcCtD
Tranylcypromine—Decreased appetite—Etoposide—muscle cancer	0.000652	0.00469	CcSEcCtD
Tranylcypromine—Constipation—Etoposide—muscle cancer	0.000641	0.00462	CcSEcCtD
Tranylcypromine—Pain—Etoposide—muscle cancer	0.000641	0.00462	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—muscle cancer	0.000636	0.00457	CcSEcCtD
Tranylcypromine—Diarrhoea—Vincristine—muscle cancer	0.000633	0.00456	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—muscle cancer	0.000632	0.00455	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—muscle cancer	0.000632	0.00455	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—muscle cancer	0.000632	0.00455	CcSEcCtD
Tranylcypromine—Feeling abnormal—Etoposide—muscle cancer	0.000618	0.00445	CcSEcCtD
Tranylcypromine—Nausea—Dactinomycin—muscle cancer	0.000616	0.00443	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Etoposide—muscle cancer	0.000613	0.00441	CcSEcCtD
Tranylcypromine—Dizziness—Vincristine—muscle cancer	0.000612	0.00441	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—muscle cancer	0.00061	0.00439	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—muscle cancer	0.000596	0.00429	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—muscle cancer	0.000593	0.00427	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—muscle cancer	0.000593	0.00427	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—muscle cancer	0.00059	0.00424	CcSEcCtD
Tranylcypromine—Vomiting—Vincristine—muscle cancer	0.000589	0.00424	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—muscle cancer	0.000585	0.00421	CcSEcCtD
Tranylcypromine—Rash—Vincristine—muscle cancer	0.000584	0.0042	CcSEcCtD
Tranylcypromine—Dermatitis—Vincristine—muscle cancer	0.000583	0.0042	CcSEcCtD
Tranylcypromine—Headache—Vincristine—muscle cancer	0.00058	0.00417	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—muscle cancer	0.000569	0.0041	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—muscle cancer	0.000567	0.00408	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—muscle cancer	0.000559	0.00402	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—muscle cancer	0.000557	0.00401	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—muscle cancer	0.00055	0.00396	CcSEcCtD
Tranylcypromine—Nausea—Vincristine—muscle cancer	0.00055	0.00396	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—muscle cancer	0.000548	0.00394	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—muscle cancer	0.000548	0.00394	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000545	0.00392	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—muscle cancer	0.000538	0.00387	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—muscle cancer	0.000519	0.00373	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—muscle cancer	0.000513	0.00369	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—muscle cancer	0.00051	0.00367	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—muscle cancer	0.000509	0.00366	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—muscle cancer	0.000508	0.00366	CcSEcCtD
Tranylcypromine—Dizziness—Etoposide—muscle cancer	0.000496	0.00357	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—muscle cancer	0.000493	0.00355	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—muscle cancer	0.000491	0.00354	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—muscle cancer	0.000484	0.00348	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—muscle cancer	0.000477	0.00343	CcSEcCtD
Tranylcypromine—Rash—Etoposide—muscle cancer	0.000473	0.0034	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—muscle cancer	0.000472	0.0034	CcSEcCtD
Tranylcypromine—Headache—Etoposide—muscle cancer	0.00047	0.00338	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—muscle cancer	0.000458	0.0033	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—muscle cancer	0.000453	0.00326	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—muscle cancer	0.000449	0.00323	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—muscle cancer	0.000445	0.00321	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—muscle cancer	0.000441	0.00317	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—muscle cancer	0.00044	0.00317	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—muscle cancer	0.000438	0.00315	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—muscle cancer	0.000434	0.00313	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—muscle cancer	0.000428	0.00308	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—muscle cancer	0.000427	0.00308	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—muscle cancer	0.000427	0.00307	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—muscle cancer	0.000421	0.00303	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—muscle cancer	0.00042	0.00302	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—muscle cancer	0.000419	0.00301	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—muscle cancer	0.000411	0.00296	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—muscle cancer	0.000406	0.00292	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—muscle cancer	0.000404	0.00291	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—muscle cancer	0.000403	0.0029	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—muscle cancer	0.000399	0.00287	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—muscle cancer	0.000397	0.00286	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—muscle cancer	0.000392	0.00282	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—muscle cancer	0.000391	0.00281	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—muscle cancer	0.000389	0.0028	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—muscle cancer	0.000384	0.00276	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—muscle cancer	0.000383	0.00275	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000381	0.00274	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—muscle cancer	0.00038	0.00273	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000376	0.00271	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—muscle cancer	0.000371	0.00267	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—muscle cancer	0.00037	0.00266	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000367	0.00264	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—muscle cancer	0.000363	0.00262	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—muscle cancer	0.000357	0.00257	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—muscle cancer	0.000355	0.00256	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—muscle cancer	0.000355	0.00256	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—muscle cancer	0.000352	0.00253	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—muscle cancer	0.000349	0.00251	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—muscle cancer	0.000346	0.00249	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—muscle cancer	0.000338	0.00243	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—muscle cancer	0.000333	0.00239	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—muscle cancer	0.000333	0.00239	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—muscle cancer	0.000322	0.00232	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—muscle cancer	0.000321	0.00231	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000318	0.00229	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—muscle cancer	0.000309	0.00222	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—muscle cancer	0.000308	0.00221	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—muscle cancer	0.000308	0.00221	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—muscle cancer	0.000307	0.00221	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—muscle cancer	0.000297	0.00214	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—muscle cancer	0.000286	0.00206	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—muscle cancer	0.000283	0.00204	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—muscle cancer	0.000283	0.00204	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—muscle cancer	0.000281	0.00203	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—muscle cancer	0.000279	0.00201	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—muscle cancer	0.000267	0.00192	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—muscle cancer	0.000266	0.00192	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—muscle cancer	0.000257	0.00185	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—muscle cancer	0.000247	0.00178	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—muscle cancer	0.000245	0.00177	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—muscle cancer	0.000245	0.00176	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—muscle cancer	0.000244	0.00175	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—muscle cancer	0.000231	0.00166	CcSEcCtD
